Shares of Aurobindo Pharma Ltd. traded 0.5 per cent down at Rs 688.8 at 02:04PM (IST) on Wednesday, even as BSE benchmark Sensex gained 607.13 points to 58550.78.
The scrip had closed at Rs 692.25 in the previous session. The stock quoted a 52-week high price of Rs 1063.75 and 52-week low of Rs 584.2, respectively. As per BSE data, total traded volume on the counter till 02:04PM (IST) stood at 45823 shares with a turnover of Rs 3.15 crore.
At the prevailing price, shares of the company traded at 14.07 times its trailing 12-month EPS of Rs 49.04 per share and 2.36 times its price-to-book value, exchange data showed.
A higher P/E ratio shows investors are willing to pay a higher share price today because of growth expectations in the future.
Price-to-book value indicates the inherent value of a company and reflects the price investors are ready to pay even for no growth in the business. The stock’s Beta value, which measures its volatility in relation to the broader market, stood at 1.06.
Shareholding Details
Promoters held 48.76 per cent stake in the company as of 31-Dec-2021, while FIIs owned 21.37 per cent and DIIs 9.56 per cent.
Technicals
On the technical charts, the relative strength index (RSI) of the stock stood at 57.47. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Chartists say, RSI should not be seen in isolation, as it may not be sufficient to take a trading call, just the way fundamental analysts cannot give a’buy’ or’sell’ recommendation using a single valuation ratio.
(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Shares of Aurobindo Pharma Ltd. traded 0.5 per cent down at Rs 688.8 at 02:04PM (IST) on Wednesday, even as BSE benchmark Sensex gained 607.13 points to 58550.78. The scrip had closed at Rs 692.25 in the previous session. The stock quoted a 52-week high price of Rs 1063.75 and 52-week low of Rs 584.2, respectively. As per BSE data, total traded volume on the counter till 02:04PM (IST) stood at 45823 shares with a turnover of Rs 3.15 crore. At the prevailing price, shares of the company traded at 14.07 times its trailing 12-month EPS of Rs 49.04 per share and 2.36 times its price-to-book value, exchange data showed. A higher P/E ratio shows investors are willing to pay a higher share price today because of growth expectations in the future. Price-to-book value indicates the inherent value of a company and reflects the price investors are ready to pay even for no growth in the business. The stock’s Beta value, which measures its volatility in relation to the broader market, stood at 1.06. Shareholding Details Promoters held 48.76 per cent stake in the company as of 31-Dec-2021, while FIIs owned 21.37 per cent and DIIs 9.56 per cent. Technicals On the technical charts, the relative strength index (RSI) of the stock stood at 57.47. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Chartists say, RSI should not be seen in isolation, as it may not be sufficient to take a trading call, just the way fundamental analysts cannot give a’buy’ or’sell’ recommendation using a single valuation ratio. (What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.) Download The Economic Times News App to get Daily Market Updates & Live Business News.